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Abstract
Background: The purpose of this study was to examine the acute effects of a weight loss
supplement on resting oxygen uptake (VO2), respiratory quotient (RQ), caloric expenditure (kcal),
heart rate (HR), and blood pressure (BP) in healthy and physically active individuals.
Methods: Ten subjects (5 male, 5 female; 20.2 ± 1.2 y; 172.2 ± 8.9 cm; 71.5 ± 17.2 kg; 17.3 ± 2.6%
body fat) underwent two testing sessions administered in a randomized and double-blind fashion.
During each session, subjects reported to the Human Performance Laboratory after at least 3-h
post-absorptive state and were provided either 3 capsules of the weight loss supplement (SUP),
commercially marketed as Meltdown® or 3 capsules of a placebo (P). Subjects then rested in a semi-
recumbent position for three hours. VO2 and HR were determined every 5 min during the first 30
min and every 10 min during the next 150 min. BP was determined every 15 min during the first
30 min and every 30 min thereafter. The profile of mood states was assessed every 30 min.
Results: Area under the curve analysis revealed a significant 28.9% difference in VO2 between SUP
and P for the three hour study period. In addition, a significant difference in energy expenditure
was also seen between SUP (1.28 ± 0.33 kcal·min-1) and P (1.00 ± 0.32 kcal·min-1). A trend (p =
0.06) towards a greater utilization of stored fat as an energy source was also demonstrated (0.78
± 0.23 kcal·min-1 and 0.50 ± 0.38 kcal·min-1 in P and SUP, respectively). Significant elevations in HR
were seen during hours two and three of the study, and significantly higher average systolic BP was
observed between SUP (118.0 ± 7.3 mmHg) and P (111.4 ± 8.2 mmHg). No significant differences
were seen in diastolic blood pressure at any time point. Significant increases in tension and
confusion were seen in SUP.
Conclusion: Results indicate a significant increase in energy expenditure in young, healthy
individuals following an acute ingestion of a weight loss supplement. In addition, ingestion of this
supplement appears modify mood and elevate HR and systolic BP following ingestion.
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The use of energy drinks and capsules have recently been
shown to be the most popular supplement besides multi-
vitamins in the American adolescent and young adult
populations, as more than 30% of American adolescents
self-admit to using thermogenic supplements on a regular
basis [1]. The primary reason for use of these supplements
is thought to be related to their desire to reduce or control
body fat [1-3]. A number of herbal ingredients have been
proposed as being effective agents in increasing energy
expenditure and reducing body fat [4]. Although studies
examining the thermogenic effect (i.e. increase in caloric
expenditure) from high-energy supplements are limited,
several recent investigations have suggested that the com-
bination of thermogenic agents in a supplement may be
more effective in increasing the thermogenic effect than a
single herbal ingredient [5,6].
Caffeine has been shown to be an effective supplement in
enhancing lipolysis, fat oxidation, and reducing glycogen
breakdown [7,8], however when combined with other
thermogenic agents its effectiveness appears to be magni-
fied [5,6]. For many years caffeine was often combined
with ephedra that resulted in an enhanced metabolic
response leading to greater body fat loss [9,10]. However,
as a result of the Federal Drug Administration's ban on
ephedrine alkaloids in 2004 the use of alternative thera-
peutic means to combat obesity has been examined. Syn-
ephrine is a mild stimulant and is thought to contribute
to appetite suppression, increased metabolic rate and
lipolysis [11]. Synephrine is thought to stimulate specific
adrenergic receptors (β-3) that stimulate fat metabolism
without any of the negative side effects (i.e., elevated
systolic blood pressure, heart rate and thermogenic strain)
generally associated with compounds that stimulate the
other adrenergic receptors [12]. Recent research has sug-
gested that to maximize the effectiveness of synephrine as
an effective weight loss supplement it may need to be
combined with other herbal products [13]. Some of these
products may include yohimbine, yerba mate extract,
hordenine and methyl tetradecylthioacetic acid. All of
which have been shown to play a role in enhancing lipol-
ysis and increasing energy expenditure [14-16].
In addition to increasing thermogenesis many of these
supplements may also contain herbal ingredients whose
primary role is to enhance mood. Phenylethylamine is an
example of an endogenous neuroamine that has been
included in weight loss supplements. Several studies have
shown that phenylethylamine can relieve depression and
improve in clinical populations [17,18]. Much of the
work on phenylethylamine was based upon research that
demonstrated that a deficit in phenylethylamine can be
responsible for depression [19]. As a result, it has been
used both clinically to treat depression, and in energy sup-
plements to enhance mood.
Considering the high propensity in the use of these ther-
mogenic supplements, research is warranted concerning
the efficacy of these energy supplements. Thus, the pur-
pose of this study was to examine the acute effect of a
weight loss supplement containing several herbal and
botanical ingredients on resting oxygen uptake, respira-
tory quotient, caloric expenditure, heart rate, and blood
pressure in healthy and physically active individuals.
Methods
Subjects
Ten subjects (5 male, 5 female; 20.2 ± 1.2 y; 172.2 ± 8.9
cm; 71.5 ± 17.2 kg; 17.3 ± 2.6% body fat) underwent two
testing sessions administered in a randomized and dou-
ble-blind fashion. Following an explanation of all proce-
dures, risks, and benefits associated with the experimental
protocol, each subject gave his or her written informed
consent to participate in this study. The Institutional
Review Board of The College of New Jersey approved the
research protocol. Subjects who were pregnant, smokers
or taking regular medication except birth control pills
were excluded from the study. Subjects with any known
metabolic or cardiovascular disease, or psychiatric disor-
der were also excluded. Subjects were also required to
have been free of any nutritional supplements or ergo-
genic aids for 6 weeks preceding the study, and were asked
to refrain from taking any additional supplement during
the duration of the study.
Study design
The study followed a double-blind, crossover design. Sub-
jects reported to the Human Performance Laboratory on
two separate days. Each testing session was separated by
an average of 3 days (3.4 ± 2.0 d). Subjects were instructed
to refrain from consuming any caffeine products on the
day of each testing session and from performing any stren-
uous physical activity for the previous 12 hours. In addi-
tion, subjects were instructed to be at least 3 hours post-
absorptive state prior to each trial. Following a 30 min rest
period subjects were randomly provided either the sup-
plement (SUP) or the placebo (P). During the second visit
to the laboratory subjects were provided with the opposite
treatment.
Metabolic measures
Immediately following supplement ingestion subjects
were fitted with a Medgraphics preVent™ pneumotach
(Medical Graphics Corporation, St. Paul, MN) to measure
oxygen consumption (VO2) and respiratory quotient
(RQ) through open-circuit spirometry using a metabolic
measurement cart (CPX Ultima™ series, Medical Graphics
Corporation, St. Paul, MN) with breath by breath analysis.Page 2 of 9
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Measures of VO2, RQ, energy expenditure, fat oxidation
rate and heart rate (HR) using a wireless HR monitor
(Pacer, Polar CIC, Inc., Port Washington, NY) were
obtained one minute following supplement or placebo
consumption, every 5 min for the first 30 min, and every
10 min thereafter until 180 min post consumption. Blood
pressure (BP) was measured using a sphygmomanometer
and ausculatory method at 15 min and 30 min post inges-
tion, and then for every 30 min until data collection con-
cluded.
Questionnaires
The profile of mood states (POMS) was administered
seven times during each testing session. The initial POMS
administration was given as the subject reported to the
Human Performance Laboratory, and every half hour for
the three hour period following supplement ingestion. All
questionnaires were performed under controlled condi-
tions (a quiet room alone with the investigator) and the
same researcher performed all test administrations.
The POMS consists of 65 words or phrases in a Likert for-
mat questionnaire which provides measures of specific
mood states. It provides measures of tension, depression,
anger, vigor, fatigue and confusion. A total mood score is
computed by subtracting vigor from the sum of the five
other negative measures and adding 100 to avoid a nega-
tive result. McNair et al., [20] has reported internal con-
sistency of measures ranging between 0.85 to 0.95 and
test-retest reliability estimates ranging between 0.65 to
0.74. These lower coefficients of stability are thought to be
indicative of transient and fluctuating characteristics of
mood states. During all test administrations participants
were asked to describe their feelings upon how they were
feeling at that moment.
Supplement
On each visit subjects ingested either 3 capsules of Melt-
down® (SUP) or a placebo (PL). Meltdown® contains the
following: 317 mg of a proprietary blend of caffeine anhy-
drous, α-methyl tetradecylthioacetic acid, yerba mate
extract, and cAMP; 20 mg of methyl-synephrine HCl, 138
mg of a proprietary blend of β-methylphenylethylamine
and methyl-β-phenylethylamine; 9 mg of a proprietary
blend of 11-hydroxy yohimbine, yohimbine HCl, and α-
yohimbine; 20 mg of methyl-hordenine HCl. The placebo
was similar in appearance and texture to Meltdown®, but
contained only an inert substance.
Statistical analyses
Statistical analysis of the data was accomplished using a
repeated measures analysis of variance. In the event of a
significant F-ratio, LSD post-hoc tests were used for pair-
wise comparisons. RQ, HR, BP and POMS were averaged
over each hour and for the entire 3-hour study period.
Comparisons of the average 3-hour measures were ana-
lyzed using dependent T-tests. A criterion alpha level of p
≤ 0.05 was used to determine statistical significance. All
data are reported as mean ± SD.
Results
A significant difference (p = 0.01) in average energy
expenditure was seen between SUP (1.28 ± 0.33 kcal·min-
1) and P (1.00 ± 0.32 kcal·min-1) during the entire 3-hr
period (see Figure 1). Significant differences in the average
energy expenditure between the groups were also seen at
each hour of the protocol (see Table 1).
The average hourly cardiovascular response to the study
protocol is seen in Table 1. Heart rate was significantly
higher during hours two and three for SUP compared to
P. The average systolic blood pressure response in SUP
was significantly higher at each hour compared to P. The
average systolic blood pressure response for the 3-hr pro-
tocol was also significantly greater (p = 0.002) for SUP
than P (see Figure 2a). No difference between the groups
was seen in the diastolic blood pressure response (Table 1
and Figure 2b).
The average RQ was significantly lower for SUP than P at
hours two and three (see Table 1). In addition, a trend (p
= 0.06) towards a greater utilization of stored fat as an
energy source, expressed as energy expenditure from fat,
was also demonstrated during the 3-hr study protocol for
SUP compared to P (see Figure 3).
Comparisons between groups in the average profile of
mood states scores can be observed in Figure 4. No signif-
icant differences were seen in the average score for the
mood states depression, anger, vigor, and fatigue. How-
ever, a significantly higher average tension and confusion
score was observed during SUP compared to P.
Discussion
The results of this study indicate that a weight loss supple-
ment containing anhydrous caffeine, synephrine, tetrade-
cylthioacetic acid, yerba mate extract,
methylphenylethylamine, yohimbine, and hordenine is
effective in increasing acute energy expenditure in young,
healthy individuals. Ingestion of this supplement also
resulted in significant elevations in heart rate and systolic
blood pressure indicating a strong inotropic response to
this supplement. In addition, acute ingestion of this sup-
plement increased tension and confusion among subjects.
Comparisons between weight loss supplements need to
be performed carefully considering the large variability
seen in ingredients or different concentrations of ingredi-
ents. Previous research has shown that acute ingestion ofPage 3 of 9
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fee supplement significantly increased energy expenditure
12% among healthy, lean college students [6]. In this
present study, using a similar subject population the com-
bination of anhydrous caffeine, synephrine and different
herbal ingredients resulted in a 29% increase in energy
expenditure. Although differences could be related to dif-
ferences in concentrations of similar ingredients within
each supplement, the difference between these studies is
likely related to the differences in co-ingredients within
the supplement.
Caffeine and herbal supplements have been shown to
increase resting metabolic rate for up to three hours fol-
lowing ingestion [6,10,21]. These effects have been shown
in supplements combining caffeine with ephedra and
black tea [10,21], and with caffeine combined with syne-
phrine, garcinia cambogia and chromium polynicotinate
[6]. The greater energy expenditure seen in this study com-
pared to others is likely related to the additional ingredi-
ents in this supplement that have previously been found
to enhance metabolism and therefore have a synergistic
effect with known thermogenic ingredients such as caf-
feine.
Synephrine is a mild stimulant that comes from the fruit
citrus aurantium (bitter orange). It is the predominant
alkaloid from this fruit, and is thought to stimulate fat
metabolism [12]. Hordenine is an alkaloid that occurs
naturally in grains, sprouting barley and certain grasses,
but it is also found in small quantities in citrus aurantium
[22]. When infused to horses it has been shown to
increase respiratory and heart rates, however when pro-
vided orally no significant cardiorespiratory changes were
seen [23]. Other studies have suggested that hordinine
can exert its stimulating effect by inhibiting norepine-
phrine uptake [15]. Although human studies with hordi-
nine are very limited, it is likely it works synergistically
with synephrine to enhance the sympathetic response.
The elevated blood pressure and heart rate responses seen
during the SUP treatment are similar to other studies
examining weight loss supplements containing adrenergic
amines [5,6,13,24]. Synephrine is thought to increase
Average 3-Hour Energy ExpenditureFigure 1
Average 3-Hour Energy Expenditure. * = Supplement significantly (p < 0.05) different than Placebo: Data are reported 
mean ± SD.Page 4 of 9
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adrenergic amines [12], however synephrine has also
been shown to stimulate peripheral α-1 receptors result-
ing in vasoconstriction and elevations in blood pressure
[25]. Although synephrine ingested alone may not alter
blood pressure, when ingested in combination with other
active herbal ingredients does appear to elevate blood
pressure and heart rate [5,6]. The combination of syne-
phrine, caffeine and hordinine used in this study appears
to cause significant elevations in the cardiovascular
response to supplement ingestion.
The trend towards a greater utilization of stored fat as the
primary energy source, as evidenced by a lower RQ, in this
study is likely related to the combination of yohimbine,
yerba mate extract and tetradecylthioacetic acid. The pre-
cise concentrations of yohimbine and its metabolites in
this supplement are not known, thus discussion concern-
ing how these differences may have effected changes in fat
mobilization would only be speculative. Yohimbine is a
selective α-adrenoceptor antagonist that has been shown
to be effective in enhancing lipid metabolism [16,26].
However, the extent of yohimbine's effect may have been
modulated by its various metabolites within the supple-
ment. No differences in RQ between the groups were seen
in the first hour following supplementation but signifi-
cant differences were seen at hours two and three. This
may be reflective of differences in α-2 adrenoceptor block-
ing potency and half-life between the metabolites of
yohimbine [27]. Although yohimbine is a more potent α-
adrenoceptor antagonist than its metabolites, it is metab-
olized more quickly.
Yerba mate extract made from the leaves of the tree Ilex
paraguariensis has been shown to suppress appetite and
prevent diet-induced obesity in rats [28] and humans
[14]. It is thought to cause weight reduction by delaying
gastric emptying [14] and its effects may be enhanced by
caffeine [4]. Although it is proposed to have several poten-
tial health benefits besides weight loss [29], its role in ele-
vating energy expenditure or increasing lipolysis is not
well understood, and may be negligible. Tetradecylthio-
acetic acid has been shown to be effective in enhancing
fatty acid metabolism [30].
The addition of phenylethylamine as an ingredient was
thought to enhance the mood of subjects using this sup-
plement. Phenylethylamine has been shown to produce
relief of depression among a clinical population, even in
those that were unresponsive to standard treatments [18].
An advantage in the use of phenylethylamine is thought
to be related to the beneficial mood improvements seen
without producing a tolerance often associated with
amphetamines [18]. The mechanism of its effect appears
to be related to the stimulation of dopamine release [31].
This may contribute to an improved mood state and has
also been shown to potentially reduce appetite [32]. In
addition, phenylethylamine may also stimulate lipolysis
through its ability to stimulate catecholamine release and
delay reuptake [33]. The results of this study indicate that
Table 1: Average hourly cardiovascular and energy expenditure measures
Variable Baseline Hour 1 Hour 2 Hour 3
Heart Rate (b·min-1) SUP 70.4 ± 9.4 71.2 ± 11.2 74.3 ± 12.6 * 72.3 ± 9.1*
P 70.0 ± 6.2 67.9 ± 7.1 65.3 ± 5.7 64.8 ± 5.8
Systolic Blood Pressure (mmHg) SUP 112.7 ± 9.9 115.8 ± 7.7 * 121.2 ± 6.8 * 119.3 ± 8.9 *
P 110.8 ± 9.6 111.7 ± 9.0 109.7 ± 7.3 111.7 ± 7.9
Diastolic Blood Pressure (mmHg) SUP 74.0 ± 6.0 76.7 ± 9.1 76.1 ± 7.5 76.3 ± 7.7
P 75.4 ± 7.5 76.1 ± 9.6 75.7 ± 5.9 74.9 ± 6.9
Energy Expenditure (kcal·min-1) SUP 1.16 ± .36 1.25 ± .39 * 1.29 ± .34 * 1.31 ± .28 *
P 1.00 ± .35 0.96 ± .27 1.03 ± .35 1.05 ± .37
RQ SUP 0.89 ± .09 0.86 ± .05 0.80 ± .04 * 0.79 ± .04 *
P 0.89 ± .07 0.87 ± .09 0.87 ± .07 0.86 ± .07
*P < 0.05, SUP > P; SUP = Supplement; P = PlaceboPage 5 of 9
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a: Average 3-Hour Systolic Blood Pressure. * = Supplement significantly (p < 0.05) different than Placebo: 2b: Average 3-
Hour Diastolic Blood Pressure. Data are reported mean ± SD.
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Average 3-Hour Fat Utilization. Data are reported mean ± SD.
Average Profile of Mood StatesFigure 4
Average Profile of Mood States. * = Supplement significantly (p < 0.05) different than Placebo. Data are reported mean ± 
SD.
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contributed to the greater reliance on fat as an energy
source. Considering the various ingredients within this
supplement, it is possible that the greater tension and con-
fusion seen in SUP may have been a result of the adrener-
gic stimulants contained in the supplement.
In conclusion the results of this study indicate that follow-
ing an acute ingestion of a weight loss supplement con-
taining anhydrous caffeine, synephrine,
tetradecylthioacetic acid, yerba mate extract, methylphe-
nylethylamine, yohimbine, and hordenine leads to a sig-
nificant increase in energy expenditure in young, healthy
individuals. In addition, ingestion of this supplement
stimulates elevations in heart rate and blood pressure for
three hours, while increasing feelings of tension and con-
fusion. Individuals who have been diagnosed with cardi-
ovascular disease need to be aware of the significant
cardiovascular effects resulting from use of this supple-
ment. Additional research is warranted concerning the
long-term effects of consumption of this supplement, and
whether such supplementation can translate into weight
loss or improved body composition.
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